HealthDay News — Recommendations have been developed to increase human papillomavirus (HPV) vaccine uptake, according to an American Society for Clinical Oncology (ASCO) special article published online April 11 in the Journal of Clinical Oncology.
Howard H. Bailey, MD, from the University of Wisconsin Carbone Cancer Center in Madison, and colleagues discuss the potential impact of HPV-related cancers and vaccination, and offer recommendations for increasing vaccine uptake.
The authors note that despite Centers for Disease Control and Prevention recommendations, data reveal low compliance with recommended vaccinations. ASCO encourages incorporation of strategies to increase HPV vaccination, such as education and awareness, which includes dissemination of evidence-based information to the public, professionals, and policymakers. Improvements in clinical service delivery should be fostered, including promotion of HPV vaccines with other recommended vaccines for young adolescents, and providing strong recommendations for vaccination. Coverage, access, and incentives for vaccination should be considered, including delivery at multiple sites, one of which should be schools. Oncology providers should be aware of established guidelines, raise awareness of HPV-related cancers and the role of vaccinations, and serve as community educators.
“As an organization committed to lessening the burden of cancer in the United States and worldwide, ASCO has developed this statement to provide the rationale behind, and a roadmap for, increasing HPV vaccination uptake as a means of preventing HPV-related cancers and saving the lives of millions,” the authors write.
Several authors disclosed financial ties to the biopharmaceutical industry.
1. Bailey HH, Chuang LT, duPont NC, et al. American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention. J Clin Oncol. Published online ahead of print April 11, 2016. doi:10.1200/JCO.2016.67.2014.